Literature DB >> 30415303

Reply to the letter regarding NADPH oxidase inhibitor.

Hiroki Iida1, Kazuhiro Kito2, Kumiko Tanabe2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30415303     DOI： 10.1007/s00540-018-2553-1

Source DB:  PubMed          Journal:  J Anesth        ISSN： 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  4 in total

1.  Arginase overexpression and NADPH oxidase stimulation underlie impaired vasodilation induced by advanced glycation end products.

Authors:  Hany M El-Bassossy; Thikryat Neamatallah; Khadijah S Balamash; Amani T Abushareb; Malcolm L Watson
Journal:  Biochem Biophys Res Commun       Date:  2018-04-10       Impact factor: 3.575

2.  Endothelium-dependent vasodilation in the cerebral arterioles of rats deteriorates during acute hyperglycemia and then is restored by reducing the glucose level.

Authors:  Kazuhiro Kito; Kumiko Tanabe; Koji Sakata; Naokazu Fukuoka; Kiyoshi Nagase; Mami Iida; Hiroki Iida
Journal:  J Anesth       Date:  2018-05-21       Impact factor: 2.078

3.  Comparative pharmacology of chemically distinct NADPH oxidase inhibitors.

Authors:  S Wind; K Beuerlein; T Eucker; H Müller; P Scheurer; M E Armitage; H Ho; H H H W Schmidt; K Wingler
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

4.  Hyperglycemia-Mediated Oxidative Stress Increases Pulmonary Vascular Permeability.

Authors:  John S Clemmer; Lusha Xiang; Silu Lu; Peter N Mittwede; Robert L Hester
Journal:  Microcirculation       Date:  2016-04       Impact factor: 2.628
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.